Cerebrolysin IV Therapy

Advanced IV therapy to protect brain health and boost performance.

The benefits

Protect brain cells

Safeguards brain cells from degeneration. Cerebrolysin promotes neurogenesis, reduces inflammation, and regulates proteins linked to cell damage.  

Protect your brain cells

Aids cognitive recovery after brain injury or stroke. Cerebrolysin enhances blood flow, promoting neurogenesis and reducing inflammation to support healing.

Enhance mental performance

Boosts brain adaptability and strengthens neuron connections. Cerebrolysin boosts neuroplasticity, improving information processing, memory, and problem-solving.

Cerebrolysin is a neuropeptide known for its protective and regenerative effects. It mimics neurotrophic factors, strengthening synaptic connections and promoting neuroplasticity to enhance memory and learning. Beyond mental performance, Cerebrolysin shields brain cells from damage and degeneration, and supports long-term brain health and recovery after injury or stroke.

Is cerebrolysin right for you?

Cerebrolysin is a multi-functional neuropeptide that supports the treatment of brain-related conditions and enhances cognitive function to improve brain health and mental performance. It is administered via IV. 

Health considerations

Cerebrolysin may support*:

Performance goals

Cerebrolysin may promote:

*Evidence regarding the efficacy of Cerebrolysin for assisting treatment of brain injury and neurodegenerative disorders is still emerging. More research is needed to fully understand the scope of this treatment’s potential.

Common questions

How is Cerebrolysin administered?
Cerebrolysin administered via an IV.

Cerebrolysin infusions at our NYC clinic start at $800.

Cerebrolysin is generally safe and well-tolerated.

Some people experience temporary side effects, like:
– Headache
– Nausea
– Agitation
– Dizziness
– Vertigo
– Seizures

You should not receive a Cerebrolysin IV if you have any of the following health conditions or considerations:
– pregnant or breastfeeding
– treating active cancer
– severe kidney dysfunction
– severe liver dysfunction

Take your health further

Complementary services designed to enhance your whole-body health state.

NAD+ THERapy

NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme found in every cell of your body.

Hyperbaric Oxygen Therapy (HBOT)

HBOT involves breathing pure oxygen in a pressurized chamber to increase oxygenation.

Not sure which treatment is right for you?

Book a consult with one of our experienced team members and they will help you get started.

Sarode LP, Ghatage T, Mardhekar V, Verma B, Prakash A, Ugale RR. Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury. Metab Brain Dis. 2023 Oct;38(7):2401-2416. doi: 10.1007/s11011-023-01240-4. Epub 2023 Jun 5. PMID: 37273080.

Zhang Y, Chopp M, Zhang ZG, Zhang Y, Zhang L, Lu M, Zhang T, Winter S, Doppler E, Brandstäetter H, Mahmood A, Xiong Y. Cerebrolysin Reduces Astrogliosis and Axonal Injury and Enhances Neurogenesis in Rats After Closed Head Injury. Neurorehabil Neural Repair. 2019 Jan;33(1):15-26. doi: 10.1177/1545968318809916. Epub 2018 Nov 30. PMID: 30499355.

Xing S, Zhang J, Dang C, Liu G, Zhang Y, Li J, Fan Y, Pei Z, Zeng J. Cerebrolysin reduces amyloid-β deposits, apoptosis and autophagy in the thalamus and improves functional recovery after cortical infarction. J Neurol Sci. 2014 Feb 15;337(1-2):104-11. doi: 10.1016/j.jns.2013.11.028. Epub 2013 Nov 26. PMID: 24315581.

Guan X, Wang Y, Kai G, Zhao S, Huang T, Li Y, Xu Y, Zhang L, Pang T. Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway. Front Pharmacol. 2019 Oct 22;10:1245. doi: 10.3389/fphar.2019.01245. PMID: 31695614; PMCID: PMC6818051.

Rejdak K, Sienkiewicz-Jarosz H, Bienkowski P, Alvarez A. Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin. Med Res Rev. 2023 Sep;43(5):1668-1700. doi: 10.1002/med.21960. Epub 2023 Apr 13. PMID: 37052231.

Liu Z, Hu M, Lu P, Wang H, Qi Q, Xu J, Xiao Y, Fan M, Jia Y, Zhang D. Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion by increasing the levels of plasticity-related proteins and decreasing the levels of apoptosis-related proteins in the rat hippocampus. Neurosci Lett. 2017 Jun 9;651:72-78. doi: 10.1016/j.neulet.2017.04.022. Epub 2017 Apr 27. PMID: 28458021.

Sadigh-Eteghad S, Geranmayeh MH, Majdi A, Salehpour F, Mahmoudi J, Farhoudi M. Intranasal cerebrolysin improves cognitive function and structural synaptic plasticity in photothrombotic mouse model of medial prefrontal cortex ischemia. Neuropeptides. 2018 Oct;71:61-69. doi: 10.1016/j.npep.2018.07.002. Epub 2018 Jul 10. PMID: 30054019

Rejdak K, Sienkiewicz-Jarosz H, Bienkowski P, Alvarez A. Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin. Med Res Rev. 2023 Sep;43(5):1668-1700. doi: 10.1002/med.21960. Epub 2023 Apr 13. PMID: 37052231.

Fiani B, Covarrubias C, Wong A, Doan T, Reardon T, Nikolaidis D, Sarno E. Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurol Sci. 2021 Apr;42(4):1345-1353. doi: 10.1007/s10072-021-05089-2. Epub 2021 Jan 30. PMID: 33515100.

Brainin M. Cerebrolysin: a multi-target drug for recovery after stroke. Expert Rev Neurother. 2018 Aug;18(8):681-687. doi: 10.1080/14737175.2018.1500459. Epub 2018 Jul 18. PMID: 30004268.

Vester JC, Buzoianu AD, Florian SI, Hömberg V, Kim SH, Lee TMC, Matula C, Poon WS, Sandesc D, von Steinbüchel N, Strilciuc S, Vos PE, von Wild K, Muresanu D. Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series. Neurol Sci. 2021 Nov;42(11):4531-4541. doi: 10.1007/s10072-020-04974-6. Epub 2021 Feb 23. PMID: 33620612.

Redefine What’s Possible for You in 2025

Don’t miss these year-end deals!